Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy

TY - JOUR

T1 - Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy

AU - Heinz, Andrea

AU - Strachan, Clare J

AU - Gordon, Keith C

AU - Rades, Thomas

PY - 2009/8

Y1 - 2009/8

N2 - OBJECTIVES: Solid-state transformations may occur during any stage of pharmaceutical processing and upon storage of a solid dosage form. Early detection and quantification of these transformations during the manufacture of solid dosage forms is important since the physical form of an active pharmaceutical ingredient can significantly influence its processing behaviour, including powder flow and compressibility, and biopharmaceutical properties such as solubility, dissolution rate and bioavailability.KEY FINDINGS: Vibrational spectroscopic techniques such as infrared, near-infrared, Raman and, most recently, terahertz pulsed spectroscopy have become popular for solid-state analysis since they are fast and non-destructive and allow solid-state changes to be probed at the molecular level. In particular, Raman and near-infrared spectroscopy, which require no sample preparation, are now commonly used coupled to fibreoptic probes and are able to characterise solid-state conversions in-line. Traditionally, uni- or bivariate approaches have been used to analyse spectroscopic data sets; however, recently the simultaneous detection of several solid-state forms has been increasingly performed using multivariate approaches where even overlapping spectral bands can be analysed.SUMMARY: This review discusses the applications of different vibrational spectroscopic techniques to detect and monitor solid-state transformations possible for crystalline polymorphs, hydrates and amorphous forms of pharmaceutical compounds. In this context, the theoretical basis of solid-state transformations and vibrational spectroscopy and common experimental approaches are described, including recent methods of data analysis.

AB - OBJECTIVES: Solid-state transformations may occur during any stage of pharmaceutical processing and upon storage of a solid dosage form. Early detection and quantification of these transformations during the manufacture of solid dosage forms is important since the physical form of an active pharmaceutical ingredient can significantly influence its processing behaviour, including powder flow and compressibility, and biopharmaceutical properties such as solubility, dissolution rate and bioavailability.KEY FINDINGS: Vibrational spectroscopic techniques such as infrared, near-infrared, Raman and, most recently, terahertz pulsed spectroscopy have become popular for solid-state analysis since they are fast and non-destructive and allow solid-state changes to be probed at the molecular level. In particular, Raman and near-infrared spectroscopy, which require no sample preparation, are now commonly used coupled to fibreoptic probes and are able to characterise solid-state conversions in-line. Traditionally, uni- or bivariate approaches have been used to analyse spectroscopic data sets; however, recently the simultaneous detection of several solid-state forms has been increasingly performed using multivariate approaches where even overlapping spectral bands can be analysed.SUMMARY: This review discusses the applications of different vibrational spectroscopic techniques to detect and monitor solid-state transformations possible for crystalline polymorphs, hydrates and amorphous forms of pharmaceutical compounds. In this context, the theoretical basis of solid-state transformations and vibrational spectroscopy and common experimental approaches are described, including recent methods of data analysis.

KW - Chemistry, Pharmaceutical

KW - Crystallization

KW - Pharmaceutical Preparations

KW - Phase Transition

KW - Solubility

KW - Spectrum Analysis

KW - Technology, Pharmaceutical

KW - Vibration

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

U2 - 10.1211/jpp/61.08.0001

DO - 10.1211/jpp/61.08.0001

M3 - Review

C2 - 19703341

SN - 0022-3573

VL - 61

SP - 971

EP - 988

JO - The Journal of pharmacy and pharmacology

JF - The Journal of pharmacy and pharmacology

IS - 8

ER -